Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(20%)
Terminated
2(40%)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_4
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(3)

Detailed Status

Terminated2
Recruiting1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (20.0%)
Phase 42 (40.0%)
N/A2 (40.0%)

Trials by Status

recruiting120%
not_yet_recruiting120%
withdrawn120%
terminated240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5